Retatrutide's bioavailability via subcutaneous injection is approximately 95% per Phase 1 pharmacokinetic data (Coskun et al., 2022), meaning very little drug is lost at the injection site regardless of which approved location you choose
Sleep deprivation: effects on weight loss and weight loss maintenance
Vials and packaging: Glass vials that have been punctured should be placed in a sharps container
A reasonable starting point places carbohydrates around training windows
Nichols WC, Pankratz N, Marek DK, Pauciulo MW, Elsaesser VE, Halter CA, Rudolph A, Wojcieszek J, Pfeiffer RF, Foroud T, Parkinson Study Group-PROGENI Investigators (2009) Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset